Sopharma AD (WSE:SPH)
Poland · Delayed Price · Currency is PLN 12.55
-0.20 (-1.57%)
Jan 8, 2026, 7:04 PM CET
Sopharma AD Market Cap
Sopharma AD has a market cap or net worth of 3.64 billion as of January 9, 2026. Its market cap has increased by 76.70% in one year.
Market Cap
3.64B
Enterprise Value
n/a
Revenue
5.47B
Ranking
n/a
PE Ratio
13.45
Stock Price
12.55
Market Cap Chart
Since April 29, 2008, Sopharma AD's market cap has increased from 1.45B to 3.64B, an increase of 150.99%. That is a compound annual growth rate of 5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.90B | 25.11% |
| Dec 22, 2025 | 3.12B | 49.25% |
| Dec 27, 2024 | 2.09B | 3.56% |
| Dec 29, 2023 | 2.02B | 55.99% |
| Dec 29, 2022 | 1.29B | -0.80% |
| Dec 30, 2021 | 1.30B | 38.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.73B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |